Emerging anticoagulants for the treatment of venous thromboembolism : Traitement of venous thromboembolismWEITZ, Jeffrey I.Thrombosis and haemostasis. 2006, Vol 96, Num 3, pp 274-284, issn 0340-6245, 11 p.Article

New oral anticoagulants in developmentWEITZ, Jeffrey I.Thrombosis and haemostasis. 2010, Vol 103, Num 1, pp 62-70, issn 0340-6245, 9 p.Article

Emerging anticoagulant drugsWEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 4, pp 721-721, issn 1079-5642, 1 p.Article

Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndromeWEITZ, Jeffrey I.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 924-931, issn 0340-6245, 8 p.Article

New approaches to oral anticoagulation: Direct thrombin inhibitorsWEITZ, Jeffrey I.Thrombosis and haemostasis. 2009, Vol JUN, pp 11-15, issn 0340-6245, 5 p., HSConference Paper

Direct thrombin inhibitorsWEITZ, Jeffrey I; CROWTHER, Mark.Thrombosis research. 2002, Vol 106, Num 3, pp V275-V284, issn 0049-3848Article

New anticoagulant drugsWEITZ, Jeffrey I; HIRSH, Jack.Chest. 2001, Vol 119, Num 1, pp 95S-107S, issn 0012-3692, SUPArticle

The status of new anticoagulantsBATES, Shannon M; WEITZ, Jeffrey I.British journal of haematology. 2006, Vol 134, Num 1, pp 3-19, issn 0007-1048, 17 p.Article

New anticoagulantsHIRSH, Jack; O'DONNELL, Martin; WEITZ, Jeffrey I et al.Blood. 2005, Vol 105, Num 2, pp 453-463, issn 0006-4971, 11 p.Article

Update on Antithrombotic Therapy New AnticoagulantsEIKELBOOM, John W; WEITZ, Jeffrey I.Circulation (New York, N.Y.). 2010, Vol 121, Num 13, pp 1523-1532, issn 0009-7322, 10 p.Article

Emerging anticoagulant drugsBATES, Shannon M; WEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 9, pp 1491-1500, issn 1079-5642, 10 p.Article

Direct thrombin inhibitors in acute coronary syndromes: Present and futureWEITZ, Jeffrey I; BULLER, Harry R.Circulation (New York, N.Y.). 2002, Vol 105, Num 8, pp 1004-1011, issn 0009-7322Article

New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplastyEIKELBOOM, John W; WEITZ, Jeffrey I.BMJ (Overseas and retired doctors ed.). 2011, Vol 342, Num 7790, pp 224-227, issn 1759-2151, 4 p.Article

New Anticoagulants for Treatment of Venous Thromboembolism : Venous thromboembolism: Mechanisms, treatment and public awarenessGROSS, Peter L; WEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2008, Vol 28, Num 3, pp 380-386, issn 1079-5642, 7 p.Article

New anticoagulant drugsWEITZ, Jeffrey I.Journal of thrombosis and thrombolysis. 2001, Vol 12, Num 1, pp 7-17, issn 0929-5305Conference Paper

Leukocyte urokinase plasminogen activator receptor and PSGL I play a role in endogenous arterial fibrinolysisXUFANG BAI; WEITZ, Jeffrey I; GROSS, Peter L et al.Thrombosis and haemostasis. 2009, Vol 102, Num 6, pp 1212-1218, issn 0340-6245, 7 p.Article

New Antithrombotic Drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)WEITZ, Jeffrey I; HIRSH, Jack; SAMAMA, Meyer M et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 234.S-256.S, SUPArticle

New anticoagulants : beyond heparin, low-molecular-weight heparin and warfarinBATES, Shannon M; WEITZ, Jeffrey I.British journal of pharmacology. 2005, Vol 144, Num 8, pp 1017-1028, issn 0007-1188, 12 p.Article

Pharmacology and clinical potential of direct thrombin inhibitors : Novel factor Xa-and thrombin-inhibitorsLINKINS, Lori-Ann; WEITZ, Jeffrey I.Current pharmaceutical design. 2005, Vol 11, Num 30, pp 3877-3884, issn 1381-6128, 8 p.Article

Emerging therapies for stroke prevention in atrial fibrillationO'DONNELL, Martin; AGNELLI, Giancarlo; WEITZ, Jeffrey I et al.European heart journal supplements. 2005, Vol 7, Num C, pp C19-C27, issn 1520-765XArticle

Gastrointestinal bleeding with the new oral anticoagulants ― defining the issues and the management strategiesDESAI, Jay; KOLB, Jennifer M; WEITZ, Jeffrey I et al.Thrombosis and haemostasis. 2013, Vol 110, Num 2, pp 205-212, issn 0340-6245, 8 p.Article

Zinc: An important cofactor in haemostasis and thrombosisVU, Trang T; FREDENBURGH, James C; WEITZ, Jeffrey I et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 421-430, issn 0340-6245, 10 p.Article

New anticoagulantsLINKINS, Lori-Ann; WEITZ, Jeffrey I.Seminars in thrombosis and hemostasis. 2003, Vol 29, Num 6, pp 619-631, issn 0094-6176, 13 p.Article

Periprocedural Management and Approach to Bleeding in Patients Taking DabigatranWEITZ, Jeffrey I; QUINLAN, Daniel J; EIKELBOOM, John W et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 20, pp 2428-2432, issn 0009-7322, 5 p.Article

Oral Direct Factor Xa InhibitorsYEH, Calvin H; FREDENBURGH, James C; WEITZ, Jeffrey I et al.Circulation research. 2012, Vol 111, Num 8, pp 1069-1078, issn 0009-7330, 10 p.Article